The Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx ...

Express Scripts by Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today issued the following statement in response to the Federal Trade Commission's reckless insulin action: ...

The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes ...

Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, ...

The suit accuses the "Big Three" of steering diabetes patients toward high-priced insulin to benefit their bottom lines ...

The US Federal Trade Commission is accusing units of CVS, Cigna, and UnitedHealth of engaging in illegal rebate programs that drove up the price of insulin. Federal Trade Commission Office of Public ...

The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.

The Federal Trade Commission has brought an administrative complaint against three of the country's largest pharmacy benefit ...

The FTC, led by chair Lina Khan, is seeking to ultimately lower insurance premiums as well as wholesale prices, which in the ...

Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...

Regulator claims companies rigged pharmaceutical supply chain competition in their favor, forced patients to pay more for ...